
    
      -  Screening of patients at Week -2

        -  Training for all complying patients in Diabetes Program School at Week -1 with
           glucometer and patient diary distribution for SMBG

        -  Randomization in one of two groups in the ratio 1:1.

        -  The 1st stage includes 12 weeks of monotherapy with Gosogliptin or Vildagliptin.

        -  The 2nd stage includes 24 weeks of combination therapy with Gosogliptin and Metformin or
           Vildagliptin and Metformin.

        -  Follow-up period of 4 weeks.
    
  